Biotechnology innovation: A legitimacy-based view

Mark J. Ahn, Anne S. York, So Young Sohn, Payam Benyamini

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Disruptive technology platforms from emerging companies hold great promise for exploiting innovation, but often face legitimacy hurdles due to their liability of newness. Nascent firms must learn new roles with limited precedent, and establish ties with an environment that may not fully understand or value their existence. Using a legitimacy-based lens in the context of the biotechnology industry, we posit a sequential construct - cognitive, regulative, and normative legitimacy - to evaluate emergent technology platforms. Our model of biotechnology platform emergence may provide insights for understanding how breakthroughs achieve legitimacy in the scientific community, mobilize resources and talent, and attain commercial success.

Original languageEnglish
Article number1350015
JournalInternational Journal of Innovation and Technology Management
Issue number4
Publication statusPublished - 2013 Aug

All Science Journal Classification (ASJC) codes

  • Management of Technology and Innovation


Dive into the research topics of 'Biotechnology innovation: A legitimacy-based view'. Together they form a unique fingerprint.

Cite this